CRB Monitor Securities Update | January 2026
Once again, cannabis-related equities began 2026 with weakness, extending CRBs’ multi-year underperformance relative to global, broad market indexes. Cannabis-themed benchmarks ...
Once again, cannabis-related equities began 2026 with weakness, extending CRBs’ multi-year underperformance relative to global, broad market indexes. Cannabis-themed benchmarks ...
As has been the case for several years, stakeholders in the cannabis space were treated to a combination of legislative ...
As we have done for nearly a decade, CRB Monitor provides our clients with the gold standard in cannabis and ...
As we write this market commentary the US Federal Government recently ended a 40+-day shutdown due to a budgetary stalemate ...
For the better part of the last five years, we have used this space to offer monthly commentary on the ...
This month we are taking fresh look at the near-term health of the largest 20 pure play Tier 1 CRBs, ...
Please believe us, the chart below is not an AI-generated visualization. This performance really happened in August 2025 – where ...
Last month we wrote about some of the sources of risk in the cannabis equity realm, which include shrinking market ...
We periodically analyze the historical performance of several components of the publicly-traded, cannabis-related equity universe, as this information can provide ...
The CRB Monitor Securities Research team covers all aspects of the publicly-traded and the privately-held cannabis ecosystem, including the regulatory ...
